Blood culture method can lower contamination, hospital costs | Stem cells could be tested as treatment for lung conditions | Pa. university wins grants for HIV-research projects
Web Version
 
 
December 5, 2012
AABB SmartBrief
News for the transfusion medicine and cellular therapy community
SIGN UP|FORWARD|ARCHIVE

Top StorySponsored By
Blood culture method can lower contamination, hospital costs
The use of a standardized process for collecting blood cultures in a pediatric emergency setting lowered the peripheral blood culture contamination rate, according to a study in the journal Pediatrics. The decline saved an estimated $250,000 in hospital charges, researchers said. DoctorsLounge.com/HealthDay News (12/4)
Share: LinkedInTwitterFacebookGoogle+Email
Stem cells could be tested as treatment for lung conditions
Canadian researchers used human umbilical cord stem cells to protect newborn rats' lungs. The cells were able to identify and correct problems such as inflammation. Such cells could be used to treat lung diseases in newborns and adults in the future, according to the study published in the medical journal Thorax. Researchers are preparing to test the treatment in 20 people in the next two years. Metro (Canada) (12/4)
Share: LinkedInTwitterFacebookGoogle+Email
Hemo bioscience has received FDA clearance for its complement coated control cells. Hemo bioscience C3 Control Cells can be used as a control to confirm the efficacy of the AHG reagent used during Direct and Indirect Anti-Globulin tests. For details regarding pricing, manufacturing schedule, and distribution channels email us or call 866-332-2835.
Advertisement
 
Science & Health
Pa. university wins grants for HIV-research projects
The University of Pittsburgh Schools of the Health Sciences and Magee-Womens Research Institute have received grants totaling almost $11.5 million from the Bill & Melinda Gates Foundation to conduct four studies on the spread of HIV. The research includes designing a test to detect the virus in the earliest stages and examining whether hormonal contraceptives affect genital tract immune cells. American City Business Journals/Pittsburgh (12/3), San Francisco Chronicle/The Associated Press (12/3)
Share: LinkedInTwitterFacebookGoogle+Email
Study uses stem cells to treat glaucoma
Researchers in the U.K. are studying a potential treatment for glaucoma that employs patients' own stem cells. Researchers reported a 50% reduction in the loss of optic nerve fibers with the infusion of olfactory ensheathing cells near the optic nerve. The method also lessened damage to optic nerve tissue. Researchers said the method may lead to a future technique that could prevent blindness from glaucoma. Medical News Today (12/4)
Share: LinkedInTwitterFacebookGoogle+Email
Patient Blood Management Resources from AABB
AABB offers a host of tools for transfusion decision makers. Clinical guidelines, education sessions and more. AABB Members can download Getting Started in Patient Blood Management and Citations in Patient Blood Management for FREE. Visit aabb.org/pbm for more information.
Advertisement
 
Emerging Trends
More facilities make Leapfrog's top-hospitals list
Shortly after releasing patient safety grades for hospitals, the Leapfrog Group announced that 92 hospitals from 26 states are on the organization's list of this year's top hospitals. Sixty-five hospitals were on last year's list. Thirteen rural hospitals made the list this year, up from three in 2011, the group said. Modern Healthcare (subscription required) (12/4)
Share: LinkedInTwitterFacebookGoogle+Email
Industry News & Practice
Funding round pulls in about $3.6M for Innovative Trauma Care
A Series A financing round has brought in more than $3.6 million for Innovative Trauma Care, a Canadian firm that recently opened a U.S. base in San Antonio. The company will use the proceeds to prepare for the commercial release of the ITClamp Hemorrhage Control System, its first product, which already has been cleared in Canada and is used to treat excessive bleeding. American City Business Journals/San Antonio/Alamo City Beat blog (12/4)
Share: LinkedInTwitterFacebookGoogle+Email
Altravax wins $3.45M in NIAID grants to develop HIV-1 vaccine
The National Institute of Allergy and Infectious Diseases awarded Altravax two grants totaling $3.45 million to support its HIV-1 vaccine research. Altravax plans to use technology from Maxygen to develop vaccines against multiple strains of HIV-1. Genetic Engineering & Biotechnology News (12/4)
Share: LinkedInTwitterFacebookGoogle+Email
WiCell to use Agilent microarrays in stem cell testing
WiCell is incorporating Agilent Technologies' CGH+SNP microarrays into its product offering for comparative genomic hybridization and SNP analysis of mouse and human embryonic stem cells and induced pluripotent stem cells. Kathleen Shelton, senior director of genomics marketing at Agilent, said the collaboration will lead to capabilities "vital for research and commercial development." GenomeWeb Daily News (free registration) (12/4)
Share: LinkedInTwitterFacebookGoogle+Email
Government & Regulatory
Obama administration says AIDS-free generation is achievable
Secretary of State Hillary Rodham Clinton laid out a plan to achieve an AIDS-free generation during a State Department ceremony Thursday to recognize World AIDS Day. The framework calls for targeting high-risk populations, providing earlier treatment of HIV infections and implementing faster expansion of proven tools. Yahoo/The Associated Press (11/29)
Share: LinkedInTwitterFacebookGoogle+Email
CMS urged to release final rule on sunshine law this month
Medtronic and the Pew Charitable Trusts have asked CMS to issue a final rule this month governing the sunshine law, which mandates that med-tech firms and other health care companies report payments made to hospitals and doctors. "Many companies have already invested significant resources in preparing to comply with the sunshine provision," representatives wrote in a letter to CMS Acting Administrator Marilyn Tavenner. MassDevice.com (Boston) (12/3), Reuters (11/28)
Share: LinkedInTwitterFacebookGoogle+Email
Association News
"Auditing in the Transfusion Service" available in AABB digital downloads library
AABB has made "Auditing in the Transfusion Service" available in its Digital Downloads library. The publication begins with an overview of auditing fundamentals and also provides details on how to conduct transfusion service audits. The text is supplemented by sample forms, templates, charts and other tools that can be customized by each user. Purchasing information is available in the AABB Marketplace.
Share: LinkedInTwitterFacebookGoogle+Email
Who's Hiring?
Position TitleCompany NameLocation
West Coast Account ManagerMacopharma USAUS - Nationwide
Director, LaboratorySan Diego Blood BankUS - CA - San Diego
Director, Patient Blood ManagementAABBUS - MD - Bethesda
Click here to view more job listings.
 
SmartQuote
The forceps of our minds are clumsy things and crush the truth a little in the course of taking hold of it."
-- H.G. Wells,
British author
Share: LinkedInTwitterFacebookGoogle+Email
Learn more about AABB® ->Homepage | Join AABB | Conferences | Marketplace | AABB CareerLink
Subscriber Tools
Please contact one of our specialists for advertising opportunities, editorial inquiries, job placements, or any other questions.
 
Editor:  Tom Parks
Managing Editor:  Amanda Horn
Advertising Manager:  Annette Bacchus
  M: 240.333.6604
 
 

Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2014 SmartBrief, Inc.®
Privacy policy |  Legal Information